openPR Logo
Press release

Current developments in Neurodegenerative Treatments

07-03-2012 10:12 PM CET | Health & Medicine

Press release from: SMi Group

The central nervous system is a fundamental part of the human body's response system, creating a massive range of reactions, targets, and in turn, diseases. With increasing average life expectancy, this wide range of disorders (from Alzheimer’s, to Parkinson’s, MS, dementia and depression), is becoming increasingly widespread in the population creating an ever greater need for new treatments and therapies.

Clinical trials are still an important area of discussion, with increasing efficiency in R&D and clinical trials as an essential part of the pharma industry. Clinical trials in the CNS industry must therefore operate a minefield of varying regulations and logistical difficulties, in order to develop a drug from discovery to market.

Johan Luthman, Senior Programme Leader Merck & Co. will speak at SMi’s Clinical Trials in CNS event held in London on the 5th & 6th November on the new opportunities to follow brain function and dysfunction a research on Alzheimers’s disease. He will discuss the critical AD biomarker validation and qualification work done via public-private pre competitive partnerships and detecting very early stages of AD pathology and following the disease progression with new technologies.

Register today to hear about the current development in neurodegenerative treatments from top pharma companies and academics. For further information and to register visit http://www.smi-online.co.uk/goto/clinicaltrials-research14.asp and quote OPENPR. Or contact Ninica Hussain on tel +44 0 207 827 6186 or email nhussain@smi-online.co.uk

The SMi Group is a world leader in business to business information. With nearly two decades in the business, thousands of senior executives from blue chip companies have already benefitted from SMi’s highly targeted conferences, workshops and publications. For more information visit www.smi-online.co.uk

SMi Group Ltd
2nd Floor South, Harling House 47-51 Great Suffolk Street,
London, SE1 0BS

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Current developments in Neurodegenerative Treatments here

News-ID: 227336 • Views: 2342

More Releases from SMi Group

Exclusive updates on the UK MoD’s LE TacCIS Programme at Future Armoured Vehic …
SMi Reports: Senior representative from the UK MoD will be presenting updates on the LE TacCIS programme at the conference in London, next April SMi Group’s 5th Annual Future Armoured Vehicles Situational Awareness Conference will be held on the 1st and 2nd April 2020, in London. The event provides a great opportunity to collaborate with technical leads, platform managers and programme directors to share their insights on the latest systems
Pharma Microbiology UK Conference to discuss Environmental Monitoring
SMi Reports: The Pharmaceutical Microbiology UK conference, taking place on 20 and 21 January 2020 in London, will include a variety of innovative presentations from the environmental monitoring field. With the slowdown in world economic growth, the Pharmaceutical & Biotechnology Environmental Monitoring industry has suffered a certain impact. However, it has still maintained a relatively optimistic growth over the past four years, as the market size maintained an annual growth rate
Exclusive platform updates on the ASCOD, AJAX, Challenger 2, Warrior IFV, PATRIA …
SMi Reports: Senior experts to present exclusive communication and systems updates at the Future Armoured Vehicles Situational Conference in London, next April SMi Group’s 5th Annual Future Armoured Vehicles Situational Awareness will commence on the 1st and 2nd April 2020, in London. The conference will delve deeper into the role of industry, inviting technical leads, platform managers and programme directors to share their insights on the latest systems and sub-systems, providing
Registration Opens for Future Armoured Vehicles Situational Awareness 2020 in Lo …
SMi reports: The agenda has been released for the upcoming Future Armoured Vehicles Situational Awareness Conference, taking place in London in April 2020. In an increasingly complex and congested digital battlespace, the need to provide near real-time information on the whereabouts of an adversary’s location and intent, using enhanced situational awareness capabilities, is vital in aiding armoured units to respond quickly to incoming threats. It is therefore imperative for defence forces

All 5 Releases


More Releases for Clinical

Clinical Research and Clinical Trials Summit
Clinical Research 2019 has been designed in an interdisciplinary manner with a multitude of tracks to choose from every segment and provides you with a unique opportunity to meet up with peers from both industry and academia and establish a scientific network between them. We cordially invite all concerned people to come join us at our event and make it successful by your participation. This is the premier interdisciplinary forum for
Clinical Trial Management System
According to a new market report published by Persistence Market Research “Global Market Study on Clinical Trial Management System: Asia to Witness Highest Growth by 2019” the global clinical trial management system market was valued at USD 844.0 million in 2013 and is expected to grow at a CAGR of 14% from 2014 to 2019, to reach an estimated value of USD 1,848.5 million in 2019. Request Report TOC @ https://www.persistencemarketresearch.com/methodology/3017
Clinical Chemistry Analyzers Sales Market
This report studies the global Clinical Chemistry Analyzers market status and forecast, categorizes the global Clinical Chemistry Analyzers market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Get FREE and detailed sample copy of updated Analysis & Status @ https://www.researchtrades.com/request-sample/1556228 Scope
Clinical Nutrition Conference 2018
Clinical nutrition is essential for patients in healthcare to deal with sickness, injuries, surgery and for proper recovery. It helps in preventing malnutrition, restoring body tissue and boosting energy and immunity in the body. It can be provided with a proper diet plan and feeding the patient with essential foods that revive the patient’s body the patient can also be given healthy supplements for proteins, vitamins etc. The preferred route
Clinical Communication
According to a recent market report published by Persistence Market Research titled “Clinical Communication and Collaboration Market: Global Industry Analysis (2012–2016) and Forecast (2017–2025),” revenue from the global clinical communication and collaboration market was US$ 138.5 Mn in 2012 and US$ 214.8 Mn in 2016, representing a CAGR of 11.6% from 2012 to 2016. This revenue growth is attributed to addition of new features in clinical communication and collaboration solutions.
Europe Clinical Nutrition Market
According to the report “Europe Clinical Nutrition Market,” published by Market Data Forecast, the global market is projected to reach USD 12.45 billion by 2021 from USD 9.65 billion in 2016, at a CAGR of 5.29% from 2016 to 2021. Clinical nutrition is the practice of analysing if a person is consuming an adequate amount of nutrients for good health. A clinical nutritionist is concerned with how nutrients in food are